Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).
about
Hereditary Angioedema Caused By C1-Esterase Inhibitor Deficiency: A Literature-Based Analysis and Clinical Commentary on Prophylaxis Treatment StrategiesNovel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency.Recurrent angioedema and the threat of asphyxiation.Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group.Factor XII mutations, estrogen-dependent inherited angioedema, and related conditions.Management of acute attacks of hereditary angioedema: potential role of icatibant.Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment.Brazilian guidelines for the diagnosis and treatment of hereditary angioedema.Hereditary Angioedema and Gastrointestinal Complications: An Extensive Review of the Literature.An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II.Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema.Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-QoL): Spanish multi-centre research project.Role of the bradykinin B2 receptor in a rat model of local heart irradiation.New treatments addressing the pathophysiology of hereditary angioedemaSocial costs of icatibant self-administration vs. health professional-administration in the treatment of hereditary angioedema in Spain.Using a bradykinin blocker in ACE inhibitor-associated angioedema in the emergency department.Successful treatment of acute hereditary angioedema attacks with self-administered icatibant in patients with venous access problems.Hereditary angioedema: epidemiology, management, and role of icatibantWAO Guideline for the Management of Hereditary AngioedemaOestrogen-dependent hereditary angio-oedema with normal C1 inhibitor: description of six new cases and review of pathogenic mechanisms and treatment.Treatment of hereditary angioedema with plasma-derived C1 inhibitorPlasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeabilityDipeptidyl peptidase IV in angiotensin-converting enzyme inhibitor associated angioedema.Clinical Immunology Review Series: An approach to the patient with angio-oedema.Ecallantide: its pharmacology, pharmacokinetics, clinical efficacy and tolerability.Therapeutic approaches in hereditary angioedema.Conestat alfa for the treatment of angioedema attacks.New topics in bradykinin research.Human pasteurized C1-inhibitor concentrate for the treatment of hereditary angioedema due to C1-inhibitor deficiency.Current management options for hereditary angioedema.Icatibant , the bradykinin B2 receptor antagonist with target to the interconnected kinin systems.Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic.Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema.Neuropeptides: metabolism to bioactive fragments and the pharmacology of their receptors.Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study.Current treatment options for hereditary angioedema due to C1 inhibitor deficiency.Icatibant as acute treatment for hereditary angioedema in adults.A Decade of Change: Recent Developments in Pharmacotherapy of Hereditary Angioedema (HAE).The Story of Angioedema: from Quincke to Bradykinin.Factor XII gene missense mutation Thr328Lys in an Arab family with hereditary angioedema type III.
P2860
Q28972400-DACC5898-53FB-4602-BAAA-F20E97DAC3E5Q33560367-65132F79-8138-41BB-AA7B-E5FB0828C8CEQ33946601-BEF49031-EACD-442C-88CB-7286F70F700CQ34029593-AAEEBA13-1B82-48F5-BA8E-14B8ED0B453DQ34060658-B829A3E5-2860-4E62-AA48-83737CE1611FQ34139106-5CD66DF1-47CF-4617-A2BC-9D51A275C287Q34579883-21969475-74D9-4DB1-B487-925849BBFD97Q35188409-BB7F9E1B-1EE3-4E69-9352-221B9D0FB306Q35961086-6269D464-6AC1-4C66-9650-AF482336C78AQ36307805-0A00D64F-B3B1-43C6-BEE3-03FBF6F74D79Q36326043-2A4C242D-CDB0-42A6-9A0F-F95E9A415C07Q36373700-77DB1543-EA02-45CC-9D45-A672066D862CQ36552117-988CBA9B-D2C8-4A2A-A36E-ABCD07D95D10Q36642688-D3A90663-12D2-4D69-BC55-3DE56B5305C0Q36646147-00071E06-32CF-458E-8FD8-40F24F14E9DEQ36703230-4455DF36-965B-4F43-BE19-98462C43A758Q36820332-F604969C-2DB1-4C87-AA8A-037D355A22F7Q36825274-5498BFFA-1A7B-46BB-ABB1-F03C8CA456B1Q36834816-0E7A7D12-1AED-44E4-8163-68048C7BA598Q37028371-D9811FF3-5CA6-4212-A6EF-D5D911AF5EC8Q37052806-4B564EA9-3F3B-4F4D-A739-CC848C53E290Q37161400-46EC57D0-C2FF-4CA1-B2EC-4533B02CAF54Q37359802-2A10ECEB-F8A9-45BB-A59C-F6204BD45DF3Q37394385-C5F3BF8D-5891-46AF-AC1C-69480B34CEA5Q37729036-99FE70B1-11F7-4FA9-A1CB-00E6EE23AEF7Q37833531-C937158E-B87C-4C25-8634-D75AE148E963Q37900837-43424AE7-D11D-496F-8B2C-D317E8056B61Q37920922-81BCB5D5-6F61-49C8-A091-B2D90183C71BQ37947670-6244B97B-C7B3-40AF-9AF4-180A18A4C77AQ38021414-72B02022-C1F1-49F9-9035-138D902AE90DQ38042696-BECA850D-35EC-4B2C-9C97-555E47C1DA48Q38058560-3F057638-C698-4021-A78E-B6783863AE6AQ38196412-6F0D293D-BB00-48B0-BB27-0984FB1F3FA0Q38217456-C70EBCBE-2482-41A7-8640-C2DF4264AB0DQ38443205-6B41EFAE-4057-4FBC-8776-8858AB686964Q38619062-254EE07D-39FB-4DD6-AF2B-83121BAF0D3DQ38819740-919F1850-1F29-45AA-A34F-E3529D204FBAQ38840241-59E7F0F2-CBFF-4416-A091-F1D89FD937AFQ38855032-ED450745-6CB7-4D0F-8108-3ADE7EBE0403Q38887662-F34980BD-901E-40B0-ADBE-50F61E4B3DBD
P2860
Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Treatment of acute edema attac ...... ptor-2 antagonist (Icatibant).
@ast
Treatment of acute edema attac ...... ptor-2 antagonist (Icatibant).
@en
Treatment of acute edema attac ...... adykinin receptor-2 antagonist
@nl
type
label
Treatment of acute edema attac ...... ptor-2 antagonist (Icatibant).
@ast
Treatment of acute edema attac ...... ptor-2 antagonist (Icatibant).
@en
Treatment of acute edema attac ...... adykinin receptor-2 antagonist
@nl
prefLabel
Treatment of acute edema attac ...... ptor-2 antagonist (Icatibant).
@ast
Treatment of acute edema attac ...... ptor-2 antagonist (Icatibant).
@en
Treatment of acute edema attac ...... adykinin receptor-2 antagonist
@nl
P2093
P1476
Treatment of acute edema attac ...... ptor-2 antagonist (Icatibant).
@en
P2093
Boris Grundt
Jorge Frank
Juerg Nussberger
Konrad Bork
Peter Schlattmann
Wolfhart Kreuz
P304
P356
10.1016/J.JACI.2007.02.012
P407
P577
2007-04-05T00:00:00Z